Search results with tag "Agonist anti cd137 monoclonal antibody"

Results from an Integrated Safety Analysis of Urelumab, an ...

Cancer Therapy: Clinical Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody Neil H. Segal1,Theodore F. Logan2, F ...

  Analysis, Safety, Integrated, Anti, Agonist, Antibody, Monoclonal, Integrated safety analysis of urelumab, Urelumab, Agonist anti cd137 monoclonal antibody, Cd137